Suprasellar cysts: clinical presentation, surgical indications, and optimal surgical treatment

<p>Abstract</p> <p>Background</p> <p>To describe the clinical presentation of suprasellar cysts (SSCs) and surgical indications, and compare the treatment methods of endoscopic ventriculocystostomy (VC) and ventriculocystocisternotomy (VCC).</p> <p>Methods&l...

Full description

Bibliographic Details
Main Authors: Zhang Ya-Zhuo, Zong Xu-Yi, Wang Xin-Sheng, Gui Song-Bai, Li Chu-Zhong
Format: Article
Language:English
Published: BMC 2011-05-01
Series:BMC Neurology
Subjects:
Online Access:http://www.biomedcentral.com/1471-2377/11/52
_version_ 1818270033840701440
author Zhang Ya-Zhuo
Zong Xu-Yi
Wang Xin-Sheng
Gui Song-Bai
Li Chu-Zhong
author_facet Zhang Ya-Zhuo
Zong Xu-Yi
Wang Xin-Sheng
Gui Song-Bai
Li Chu-Zhong
author_sort Zhang Ya-Zhuo
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>To describe the clinical presentation of suprasellar cysts (SSCs) and surgical indications, and compare the treatment methods of endoscopic ventriculocystostomy (VC) and ventriculocystocisternotomy (VCC).</p> <p>Methods</p> <p>We retrospectively reviewed the records of 73 consecutive patients with SSC who were treated between June 2002 and September 2009. Twenty-two patients were treated with VC and 51 with VCC. Outcome was assessed by clinical examination and magnetic resonance imaging.</p> <p>Results</p> <p>The patients were divided into five groups based on age at presentation: age less than 1 year (n = 6), 1-5 years (n = 36), 6-10 years (n = 15), 11-20 years (n = 11), and 21-53 years (n = 5). The main clinical presentations were macrocrania (100%), motor deficits (50%), and gaze disturbance (33.3%) in the age less than 1 year group; macrocrania (75%), motor deficits (63.9%), and gaze disturbance (27.8%) in the 1-5 years group; macrocrania (46.7%), symptoms of raised intracranial pressure (ICP) (40.0%), endocrine dysfunction (40%), and seizures (33.3%) in the 6-10 years group; symptoms of raised ICP (54.5%), endocrine dysfunction (54.5%), and reduced visual field or acuity (36.4%) in the 11-20 years group; and symptoms of raised ICP (80.0%) and reduced visual field or acuity (40.0%) in the 21-53 years group. The overall success rate of endoscopic fenestration was 90.4%. A Kaplan-Meier curve for long-term efficacy of the two treatment modalities showed better results for VCC than for VC (p = 0.008).</p> <p>Conclusions</p> <p>Different age groups with SSCs have different main clinical presentations. VCC appears to be more efficacious than VC.</p>
first_indexed 2024-12-12T21:03:51Z
format Article
id doaj.art-412686a793534bf6a8adefba4de97dd9
institution Directory Open Access Journal
issn 1471-2377
language English
last_indexed 2024-12-12T21:03:51Z
publishDate 2011-05-01
publisher BMC
record_format Article
series BMC Neurology
spelling doaj.art-412686a793534bf6a8adefba4de97dd92022-12-22T00:12:04ZengBMCBMC Neurology1471-23772011-05-011115210.1186/1471-2377-11-52Suprasellar cysts: clinical presentation, surgical indications, and optimal surgical treatmentZhang Ya-ZhuoZong Xu-YiWang Xin-ShengGui Song-BaiLi Chu-Zhong<p>Abstract</p> <p>Background</p> <p>To describe the clinical presentation of suprasellar cysts (SSCs) and surgical indications, and compare the treatment methods of endoscopic ventriculocystostomy (VC) and ventriculocystocisternotomy (VCC).</p> <p>Methods</p> <p>We retrospectively reviewed the records of 73 consecutive patients with SSC who were treated between June 2002 and September 2009. Twenty-two patients were treated with VC and 51 with VCC. Outcome was assessed by clinical examination and magnetic resonance imaging.</p> <p>Results</p> <p>The patients were divided into five groups based on age at presentation: age less than 1 year (n = 6), 1-5 years (n = 36), 6-10 years (n = 15), 11-20 years (n = 11), and 21-53 years (n = 5). The main clinical presentations were macrocrania (100%), motor deficits (50%), and gaze disturbance (33.3%) in the age less than 1 year group; macrocrania (75%), motor deficits (63.9%), and gaze disturbance (27.8%) in the 1-5 years group; macrocrania (46.7%), symptoms of raised intracranial pressure (ICP) (40.0%), endocrine dysfunction (40%), and seizures (33.3%) in the 6-10 years group; symptoms of raised ICP (54.5%), endocrine dysfunction (54.5%), and reduced visual field or acuity (36.4%) in the 11-20 years group; and symptoms of raised ICP (80.0%) and reduced visual field or acuity (40.0%) in the 21-53 years group. The overall success rate of endoscopic fenestration was 90.4%. A Kaplan-Meier curve for long-term efficacy of the two treatment modalities showed better results for VCC than for VC (p = 0.008).</p> <p>Conclusions</p> <p>Different age groups with SSCs have different main clinical presentations. VCC appears to be more efficacious than VC.</p>http://www.biomedcentral.com/1471-2377/11/52Suprasellar cystclinical presentationendoscopic fenestrationoutcome
spellingShingle Zhang Ya-Zhuo
Zong Xu-Yi
Wang Xin-Sheng
Gui Song-Bai
Li Chu-Zhong
Suprasellar cysts: clinical presentation, surgical indications, and optimal surgical treatment
BMC Neurology
Suprasellar cyst
clinical presentation
endoscopic fenestration
outcome
title Suprasellar cysts: clinical presentation, surgical indications, and optimal surgical treatment
title_full Suprasellar cysts: clinical presentation, surgical indications, and optimal surgical treatment
title_fullStr Suprasellar cysts: clinical presentation, surgical indications, and optimal surgical treatment
title_full_unstemmed Suprasellar cysts: clinical presentation, surgical indications, and optimal surgical treatment
title_short Suprasellar cysts: clinical presentation, surgical indications, and optimal surgical treatment
title_sort suprasellar cysts clinical presentation surgical indications and optimal surgical treatment
topic Suprasellar cyst
clinical presentation
endoscopic fenestration
outcome
url http://www.biomedcentral.com/1471-2377/11/52
work_keys_str_mv AT zhangyazhuo suprasellarcystsclinicalpresentationsurgicalindicationsandoptimalsurgicaltreatment
AT zongxuyi suprasellarcystsclinicalpresentationsurgicalindicationsandoptimalsurgicaltreatment
AT wangxinsheng suprasellarcystsclinicalpresentationsurgicalindicationsandoptimalsurgicaltreatment
AT guisongbai suprasellarcystsclinicalpresentationsurgicalindicationsandoptimalsurgicaltreatment
AT lichuzhong suprasellarcystsclinicalpresentationsurgicalindicationsandoptimalsurgicaltreatment